Bellicum Pharmaceuticals Inc (OQ:BLCM)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BLCM within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 4/20 Feb 3/20 Foster Aaron E. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 380,000  
Feb 4/20 Feb 3/20 Smith Alan K. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 380,000  
Feb 4/20 Feb 3/20 Mokari Atabak Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 540,000  
Feb 4/20 Feb 3/20 Fair Richard A. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 1,257,000  
Feb 4/20 Feb 3/20 Ward Shane Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 410,000  
Feb 3/20 Jan 31/20 Strauss David Eric Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 156,000  
Jan 6/20 Jan 3/20 Foster Aaron E. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -625  
Jan 6/20 Jan 3/20 Foster Aaron E. Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -236 $1.40
Jan 6/20 Jan 3/20 Foster Aaron E. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 625  
Jan 6/20 Jan 3/20 Smith Alan K. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -1,563  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BLCM within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 4/20 Feb 3/20 Foster Aaron E. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 380,000  
Feb 4/20 Feb 3/20 Smith Alan K. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 380,000  
Feb 4/20 Feb 3/20 Mokari Atabak Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 540,000  
Feb 4/20 Feb 3/20 Fair Richard A. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 1,257,000  
Feb 4/20 Feb 3/20 Ward Shane Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 410,000  
Feb 3/20 Jan 31/20 Strauss David Eric Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 156,000  
Jan 6/20 Jan 3/20 Foster Aaron E. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -625  
Jan 6/20 Jan 2/20 Foster Aaron E. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -2,500  
Jan 6/20 Jan 3/20 Foster Aaron E. Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -236 $1.40
Jan 6/20 Jan 3/20 Foster Aaron E. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 625  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BLCM